• Disclaimer
• SiteMap
• Home

• about us
  • Corporate Profile
  • Board of Directors
• technology
  • GIPET®
  • Strategic Partnering
• portfolio
  • Product Pipeline
  • Strategic Partnering
  • Orazol™ (Breast Cancer)
  • Orazol™ (Bone Metastases)
  • Almerol™ (MER-103)
  • Acyline (MER-104)
  • MER-102
• investor relations
  • Corporate Profile
  • Share Information
  • Annual Reports /
    Financial Information
  • Financial Calendar
  • Investor Alert
  • Regulatory News
  • Corporate Governance
  • Analyst Coverage
  • Advisors and Registrars
  • Ownership Summary
  • Rule 26 Information
• media
• contact

Share Information

• Print page
• Email page

Number of ESM securities

17,131,509 Ordinary shares of €0.01

 

• Detailed Share Price
• Share Price Calculator